Target
HLA-DR expressing cells
2 abstracts
Abstract
Exploratory phase I study of HF1K16 for the treatment of patients with refractory/recurrent advanced glioma: Preliminary efficacy and mechanism as a monotherapy.Org: Huashan Hospital Fudan University, Fudan University (Xiamen Branch), Shanghai Henlius Biotech, China National Biotec Group, Zhejiang University, Hangzhou, China,
Abstract
The association of HLA-DR and PD-L1 expression with clinical characteristics in prostate adenocarcinoma.Org: The George Washington University School of Medicine and Health Sciences, George Washington University Milken Institute School of Public Health, The Edward P. Evans Foundation Precision Oncology Center of Excellence, Washington DC VA Medical Center,